Trials / Completed
CompletedNCT00587600
Biomarkers in Phototherapy of Barrett's Esophagus
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 208 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to find out if Photodynamic Therapy (treatment with a red light and a drug called photofrin) or Radiofrequency ablation works the same for patients who have biomarkers (abnormalities in molecules of cells that may or may not help predict cancer) present in their Barrett's esophagus as for patients who do not have biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Photodynamic therapy | Photofrin 2mg/kg Photoradiation The light dose delivered will be a total of 200 joules per centimeter fiber which has previously been shown to ablate Barrett's mucosa. |
| PROCEDURE | radiofrequency ablation of barrett's esophagus | radiofrequency ablation |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2017-04-21
- Completion
- 2017-04-21
- First posted
- 2008-01-07
- Last updated
- 2017-11-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00587600. Inclusion in this directory is not an endorsement.